{"id":"https://genegraph.clinicalgenome.org/r/5a28b51c-5838-44fa-bc25-16a16957d055v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between SURF1 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of January 14, 2019. 21 articles were reviewed. SURF1 was first reported in relation to autosomal recessive Leigh syndrome spectrum in 1998 (Tiranti et al., PMID 9837813). Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 7 probands in 4 publications (PMIDs 9837813, 10443880, 22488715, 27756633). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. This gene-disease association is supported by the known biochemical function, expression, rescue studies, and animal models. The mechanism for disease is complex IV deficiency. In summary, there is definitive evidence to support the relationship between SURF1 and autosomal recessive Leigh syndrome spectrum. More than three years have elapsed from the first proposal of the association to reach a definitive classification. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on January 14, 2019 (SOP Version 6).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/5a28b51c-5838-44fa-bc25-16a16957d055","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2019-04-08T16:03:38.698Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70609a33-6c67-438f-8fc3-1d4e74017d42","type":"EvidenceLine","dc:description":"Per Mito GCEP guidance: 0/3 points for neuropath evidence; 0/2 points for MRI evidence, 1/1 points for biochem or mito dysfunction; 0/1 point for neurocognitive/developmental difference = 1","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e83dd701-6aab-44c6-940b-4c108c14942e","type":"Finding","dc:description":"Decreased oxidative phosphorylation is included in Leigh syndrome spectrum definition","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25164807","rdfs:label":"Knock down (post-transcriptional silencing of CG9943)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5952aa0d-aaf1-48af-a703-78c4be1e53c6","type":"EvidenceLine","dc:description":"Per MitoGCEP guidance: 1/3 for neuropathological evidence; 0/2 for MRI evidence; 0.5/1 for biochem/mito dysfunction; 0.5/1 for neurocognitive/developmental differences = 2","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8a8384f9-c985-4d49-8331-4c98923e6b7e","type":"Finding","dc:description":"neuropathological evidence somewhat consistent with Leigh syndrome spectrum diagnosis, biochemical/mito evidence somewhat consistent with Leigh syndrome spectrum diagnosis; neurocognitive/developmental differences somewhat consistent with Leigh syndrome spectrum","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29601977","rdfs:label":"Knockout cloned pigs","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5710493e-bbc8-46a7-bf77-cd7a3158af3f","type":"EvidenceLine","dc:description":"Corrects COX activity (but other aspects of Leigh phenotype cannot be measured in cells)","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/711f7e58-584a-444b-adbb-393ccdb9869a","type":"Finding","dc:description":"Correction of COX deficiency","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10443880","rdfs:label":"COX activity before and after transfection","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/043b2571-9a8a-4242-bc69-3df02f4f6bbe","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3abaf5ed-4639-48fe-9ca7-8cbdf7229100","type":"FunctionalAlteration","dc:description":"Absense of SURF1 protein leads to accumulation of intermediates of COX assembly (S1 and S2), control cell lines show fully formed COX","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10556302","rdfs:label":"Blue native 2D gel electrophoresis"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5a981b4e-ded3-4aef-a6e3-49e96766ca6c","type":"EvidenceLine","dc:description":"Per LeighMap (Rahman et al., 2016), there are 4 other complex IV assembly factors (SCO2, COX10, COX15, PET100)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4d5318c7-049b-45d4-b04e-d7a94dec41e6","type":"Finding","dc:description":"These studies show decreased fully assembled complex IV when SURF1 compound heterozygous variants are present as well as decreased mitochondrial respiration rates. Leigh syndrome spectrum includes evidence of OXPHOS enzyme activity deficiency","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29933018","rdfs:label":"complex IV assembly","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/5a528b74-3f0e-4ac3-ae94-8b2103650ad4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/911ce7df-eadc-41d2-8f1e-5e462eb69bfd","type":"Finding","dc:description":"Reduction in the steady-state level of SURF1 mRNA in patient 1 with c.312_321delTCTGCCAGCCinsAT:p.L105X and c.845_846delCT:p.S282Cfs) and patient 2 with nonsense and splice variants","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9843204","rdfs:label":"northern blot","demonstrates":{"id":"cg:GeneExpressionB"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/2ed17d9b-e746-4f1f-9c39-26f46bb2eadc_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5037c399-234c-431a-b5a4-34d470de7682_proband_score_evidence_line","type":"EvidenceLine","dc:description":"c.240+1G>T destroys the canonical splice donor site in intron 3, common SURF1 variant in Europeans (Wedatilake et al 2013); c.516-2A>G affects splice acceptor site","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f364090-ad81-4f5d-9815-96b1a6e7d967","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","rdfs:label":"Case 3","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypeFreeText":"Leigh syndrome (as defined in Rahman et al., 1996) - basal ganglia lesions; developmental regression and intellectual disability; lactic acidosis","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5037c399-234c-431a-b5a4-34d470de7682_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","allele":[{"id":"https://genegraph.clinicalgenome.org/r/34327eab-485e-4a5b-808d-101fad4f6bfc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000009.12:g.133352768T>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA200832536"}},{"id":"https://genegraph.clinicalgenome.org/r/4e50d4cb-2886-4c62-95aa-3da6f8e6a86c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.240+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/379506"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/86a36725-e47d-4962-b572-6965f7c98561_proband_score_evidence_line","type":"EvidenceLine","dc:description":"c.-11_13del already counted, c.868dupT generates stop codon and protein 9 amino acids shorter than normal","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1bdd7a21-15ba-41a1-ba7e-a7738686cbdb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27756633","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"detectionMethod":"","phenotypeFreeText":"Brain MRI: bilateral hyperintense lesions of the head of the caudate nuclei, thalamic posteromedial ventral nuclei, midbrain, pons, deep cerebellar white matter, olivary nuclei and left dentate nucleus; neurodevelopmental regression; elevated lactate; muscle complex VI activity was 18.4% of controls","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/86a36725-e47d-4962-b572-6965f7c98561_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27756633","allele":[{"id":"https://genegraph.clinicalgenome.org/r/6f6a85fc-f350-4ec4-8765-730e0319c046","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.870dup (p.Lys291Terfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/520829"}},{"id":"https://genegraph.clinicalgenome.org/r/f8479410-877c-4dc1-85ec-80800496ae05","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.-11_13del24","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/215241"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/29b7f679-b824-4bd0-ad61-c53ea97026f5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Premature stop/null","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78dd07bb-b7c9-419e-a7b6-a0581f35a4be","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10443880","rdfs:label":"Patient No. 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":16,"detectionMethod":"","phenotypeFreeText":"“Typical LS” (stringent inclusion criteria for LS were adopted, as proposed by Rahman et al., 1996); muscle COX was 14% of controls","previousTesting":false,"previousTestingDescription":"","sex":"UnknownEthnicity","variant":{"id":"https://genegraph.clinicalgenome.org/r/29b7f679-b824-4bd0-ad61-c53ea97026f5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10443880","allele":{"id":"https://genegraph.clinicalgenome.org/r/43864c38-be51-417f-8f70-b302b8612e59","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.751C>T (p.Gln251Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12762"}}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/d6923062-d88d-47be-90f1-fa67ae90aca8_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Frameshift variant already counted; 2nd variant is missense, no additional functional evidence for pathogenicity","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/96c6b7a1-7ccb-46c6-bf14-d8976c413331","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","rdfs:label":"Case 5","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypeFreeText":"Leigh syndrome (as defined in Rahman et al., 1996) - lesions in subthalamic nuclei, medullar, tecmentum; developmental delay/intellectual disability; elevated blood lactate; complex IV activity was 16% of controls in muscle","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d6923062-d88d-47be-90f1-fa67ae90aca8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","allele":[{"id":"https://genegraph.clinicalgenome.org/r/7f98abcd-8459-4216-94b4-64109512b96b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.845_846delCT (p.Ser282Cysfs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/12770"}},{"id":"https://genegraph.clinicalgenome.org/r/fa95e7e6-d13a-4ee3-933e-888add501c14","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.269T>C (p.Leu90Pro)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/381516"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f84771b0-ad12-4abf-9025-c4ad71ff5f82_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Causes the loss of ATG codon, essential for the protein synthesis initiation","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2d6cb370-cdbd-42ba-9428-fa73baf0d08c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27756633","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"detectionMethod":"","phenotypeFreeText":"Brain MRI: hyperintense lesion in the head of the left caudate nucleus, symmetrical involvement of the midbrain tegmentum (arrow), involvement of periaqueductal gray matter; neurodevelopmental acute regression; elevated lactate; complex IV deficiency in muscle (22.5% of average)","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f84771b0-ad12-4abf-9025-c4ad71ff5f82_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27756633","allele":{"id":"https://genegraph.clinicalgenome.org/r/f8479410-877c-4dc1-85ec-80800496ae05"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cb35b417-6a94-41be-8a3f-2b6695fd3873_proband_score_evidence_line","type":"EvidenceLine","dc:description":"c.574_575insCTGC frameshift, premature stop; c.55-1G>A affects splice acceptor site","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aca49f1e-ef73-42b4-a603-6495cb9ed42d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","rdfs:label":"12","ageType":"AgeAtDeath","ageUnit":"Years","ageValue":4,"detectionMethod":"","ethnicity":{"id":"cg:NotHispanicOrLatino"},"phenotypeFreeText":"Leigh syndrome (as defined in Rahman et al., 1996) - lesions in basal ganglia, cerebellum, and medulla; developmental delay/intellectual disability; elevated blood lactate","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cb35b417-6a94-41be-8a3f-2b6695fd3873_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22488715","allele":[{"id":"https://genegraph.clinicalgenome.org/r/5ad5a955-1d36-4432-ba6a-62e125729fc5","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003172.3(SURF1):c.574_575insCTGC (p.Arg192Profs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/419973"}},{"id":"https://genegraph.clinicalgenome.org/r/12a7edd2-0cce-4f9b-a562-ea1fb8922835","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000009.12:g.133356321C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA375695114"}}]}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/03976fff-f71a-4b02-9b87-26fd11d9d54e_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Frameshift, premature stop; common variant","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/555c6851-617f-40a5-b86b-c79abee0598e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9837813","rdfs:label":"E","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","phenotypeFreeText":"Brain MRI/CT: symmetric lesions scattered from the basal ganglia to the brain stem and cerebellum; rapidly progressive psychomotor regression; elevated blood lactate; muscle COX ~10% of controls","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/03976fff-f71a-4b02-9b87-26fd11d9d54e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/9837813","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f98abcd-8459-4216-94b4-64109512b96b"}}}],"specifiedBy":"GeneValidityProbandARDeNovoNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":493,"specifiedBy":"GeneValidityCriteria6","strengthScore":18,"subject":{"id":"https://genegraph.clinicalgenome.org/r/MQ9VpPg4afk","type":"GeneValidityProposition","disease":"obo:MONDO_0009723","gene":"hgnc:11474","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2ed17d9b-e746-4f1f-9c39-26f46bb2eadc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}